|Application ||WB, IHC, E, DB|
|Other Names||H-FABP; Fatty acid-binding protein 3; Heart-type fatty acid-binding protein; H-FABP; Mammary-derived growth inhibitor; MDGI; Muscle fatty acid-binding protein; M-FABP|
|Reconstitution & Storage||Store at -20°C. Avoid freeze / thaw cycles. Short term storage +2°C-+8°C|
|Precautions||Fatty Acid Binding Protein (Heart) Antibody is for research use only and not for use in diagnostic or therapeutic procedures.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Fatty acid binding protein is one of a group of lowmolecular weight proteins involved in the solubilization and transport of fatty acids. The release of cytoplasmic heart fatty acid-binding protein (H-FABP) into the plasma of cardiac patients is used as a marker of cardiac damage. In 18 out of 22 patients with established AMI the plasma FABP level was at or above the threshold level in blood-samples taken within 3.5 hours after the first onset of symptoms of AMI, which compares very favourably with more established markers such as CKMB. RANDOX recombinant human FABP is expressed in E. coli with an amino-terminal hexahistidine tag. This product is for research use only and is not intended for diagnostic or therapeutic use.
Furuhashi, M. et al. (2003) Nephron Clin Pract. 93(2): C69-74.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.